Skip to content
drillr.ai
Sign up

01011.HK

China NT Pharma Group Company Limited

HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN

HKD 0.42
−1.19%
Ask drillr

  • Aug 25, 2026, 02:07 UTC

    Zhongke Tianyuan issued a profit warning, expecting its attributable loss for the six months ending June 2026 to narrow to approximately RMB 3.72 million from RMB 7.85 million a year earlier.

    Source:

  • Aug 20, 2026, 17:01 UTC

    Tailing Medicine reported interim results for the six months ended June 2026, with revenue up 97.3% year-on-year to RMB 23.67 million and net loss widening to RMB 18.43 million from RMB 16.91 million a year earlier.

    Source:

  • Aug 19, 2026, 01:51 UTC

    China International Economic and Trade Arbitration Commission ruled that Techlink Medical and related parties must pay about 92 million yuan in penalties and fees, and Techlink Medical has initiated legal procedures to apply for revocation of the award.

    Source: